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Stereotypic movementsBackground: Autism is a behaviorally defined neurodevelopmental disorder of unknown etiology.
Objective: To assess serum copper and ceruloplasmin levels in Egyptian autistic children patients.
Subjects and methods: 40 participants have been subjected to thorough history taking, complete clinical
examination, IQ assessment, estimation of serum copper and ceruloplasmin levels.
Results: A statistically significant difference was found between patients and controls as regards stereo-
typic movements, absent eye contact, delayed motor development, delayed speech and IQ (p < 0.01 for
each item). Mean level of copper was significantly higher in patients than in controls (P < 0.001), also
mean level of ceruloplasmin was significantly higher in patients than controls (P = 0.009).
Conclusion: Serum copper level may have a role in the pathogenesis of autism.
 2017 Ain Shams University. Production and hosting by Elsevier B.V. This is an open access article under
the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).1. Introduction
Autism is a syndrome characterized by impairments in social
relatedness, communication, repetitive behavior, abnormal move-
ments and sensory dysfunction [1].
Copper, an essential trace mineral, is vitally important for both
physical and mental health. Copper is critical for energy production
in the cells. It is also involved in nerve conduction, connective tis-
sue, the cardiovascular system and the immune system. Copper
stimulates production of the neurotransmitters epinephrine, nore-
pinephrine and dopamine. It is also required for monoamine oxi-
dase, an enzyme related to serotonin production [2].
Ceruloplasmin is the major copper-carrying protein in blood,
and in addition plays a role in iron metabolism. First described in
1984, ceruloplasmin carries about 70% of the total copper in
human plasma while albumin carries about 15% [3].
Autistic children are frequently subjected to oxidative stress;
hence the levels of major antioxidant serum proteins like cerulo-
plasmin (copper-binding protein) are decreased in children with
autism. Heavy metals –including copper– are found at higher val-
ues in serum of autistic individuals than their normal peers [4].2. Aim of the work
To assess serum copper and ceruloplasmin levels in Egyptian
autistic children patients.
3. Subjects and methods
The present study was designed to be of a case control type. It
enrolled 20 cases with autism diagnosed by ICD-10 (International
Classification of disease, 10th edition) and the Childhood Autism
Rating Scales (CARS), with no other medical disease. The patients
were 15 males and 5 females. Their ages ranged from 2 to 13 years
with mean of 6.15 ± 3.133 years. They were recruited from the psy-
chiatric clinic of pediatric department and psychiatric department,
Ain Shams University, during the period from December 2011 to
April 2012.
The control group enrolled 20 apparently healthy children,
matched to the patients’ age and sex. They were recruited
from the outpatient clinic, children’s hospital, Ain Shams
University. Their ages ranged from 4 to 17 years with a mean of
9.05 ± 3.605 years.
All patients were subjected to:
1. Thorough history taking laying stress on social interactions,
impairment of language, age, gender, age of onset of clinical
manifestation, presence or absence of perinatal problems and
family history of psychiatric disorders.
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logical examination.
3. Psychiatric evaluation including:
a- IQ assessment using Stanford-Binet Intelligence Scale
(1986) [5].
b- Assessment of the severity of autistic symptoms using Chil-
dren Autism Rating Scale (CARS) [6].
4. Laboratory investigations including serum copper and cerulo-
plasmin levels [7].
3.1. IQ assessment
Using Stanford-Binet Intelligence Scale (1986) was carried out
by clinical psychologists at the psychiatry department, Ain Shams
University Hospitals. IQ was calculated using the following
equation:
IQ ¼ Mental age ðMAÞ assessed using the proper test
Chronological age ðCAÞ  100
Ranges of IQ: 20–30 severe mental retardation, 31–49 moderate
mental retardation, 50–70, mild mental retardation, 71–89 below
average IQ, 90–109 normal IQ, 110–12 above average IQ and
125–140 genius.
Items of the CARS are: relating to people, imitation, emotional
response, body use, object use, adaptation to change, visual
response, listening response, taste, smell and touch response and
use, fear or nervousness, verbal communication, non verbal com-
munication, activity level, level and consistency of intellectual
response and general impressions.
3.2. Collection of blood samples
Specimen collection and storage: The usual precautions for
puncture were observed and followed. Blood samples were col-
lected by a syringe with a wide bore needle 5 ml. All samples wereTable 1
Statistical comparison between patients and controls as regards clinical data.
Variable Cases n = 20
No %
Stereotypic movements Negative 2 10
Positive 18 90
Absent eye contact Negative 3 15
positive 17 85
Delayed motor development Negative 2 10
Positive 18 90
Normal speech Negative 20 100
Positive 0 0
Convulsions Negative 19 95
Positive 1 5
M.M.R vaccination Negative 0 0
Positive 20 100
IS: insignificant. HS: High significance. NS: non significant.
Table 2
Statistical comparison between patients and controls as regards copper, ceruloplasmin lev
Parameter Case Control
Mean ± SD Mean ± SD
Copper 132.15 ± 28.019 105.46 ± 15.
70–140 lg/dl
Ceruloplasmin 35.175 ± 8.748 29.04 ± 4.48
20.4–40.7 mg/dl
IQ 52.7 ± 4.846 100.75 ± 2.4
HS: High significance.drawn from non fasting individuals. Evacuation of the sample was
done after removal of the needle very slowly over the side of the
test tube to avoid hemolysis without anticoagulant. Don’t shake
the tube to avoid hemolysis. The samples were stored at room tem-
perature for 2 h then centrifugation was done for serum separa-
tion. Serum was then collected at eppendorf tube and frozen at
20 C for storage.
3.3. Statistical methods
IBM SPSS statistics (V. 20.0, IBM Corp., USA, 2011) was used for
data analysis. Data were expressed as Mean ± SD for quantitative
parametric measures in addition to both number and percentage
for categorized data. Student t test was used to compare between
two independent mean groups for parametric data, person correla-
tion test was done to study the possible association between each
two variables among each group for parametric data. Chi-square
test was done to study the association between each 2 variables
or comparison between 2 independent groups as regards the cate-
gorized data.
The probability of error p value = 0.05 or less was considered
significant.
4. Results
A statistically highly significant difference was found between
patients and controls as regards stereotypic movement, delayed
motor development (90% of patients), absent eye contact (85% of
patients), all our patients have abnormal speech and low IQ
(p < 0.01). The difference between patients and control groups
was statistically insignificant (P > 0.05) as regards convulsions
(5% of patients). All patients and controls have taken M.M.R vaccine
(Table 1).
There was statistically highly significant difference between
mean level of copper in patients and controls (P < 0.001). CopperControls n = 20 Value P Sig.
No %
20 100 32.727ª 0.000 HS
0 0
20 100 29.565ª <0.01 HS
0 0
20 100 32.727ª <0.001 HS
0 0
0 0 40.000ª <0.001 HS
20 0
20 100 1.026ª >0.05 IS
0 0




607 3.72 0.001 HS
1 2.79 0.009 HS










Ceruloplasmin (mg/dl) 29 35.2
copper(μg/dl) 105 132
Fig. 1. Comparison between controls and patients as regards mean values of copper and ceruloplasmin.
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controls (132.15 vs. 105.46 lg/dl). There was statistically highly
significant difference between mean level of ceruloplasmin in
patients and controls (P = 0.009). Ceruloplasmin level was higher
in 15% of patients compared to normal level in controls (35.175
vs. 29.04 mg/dl). Using ‘‘t” test there was statistically highly signif-
icant difference between Intelligence Quotient level (IQ) in
patients and controls (P<0.01) being lower in patients than con-
trols (Table 2) (Fig. 1).
5. Discussion
Autism spectrum disorders encompass a spectrum of develop-
mental disorders, characterized by impairment in the development
of language, communication and reciprocal social interaction,
together with a restricted repertoire of activities [8].
The Centers for Disease Control and prevention estimates that
the current prevalence of autism spectrum disorders among 11
sites in the United States is 1 in 68 children aged 8 years [8].
Despite numerous structural and functional neuroimaging studies,
as well as post-mortem investigations, the underlying neurobio-
logical basis of autism continues to remain elusive [9]. On the other
hand, awareness of the prevalence of autism in the Arab world is
still very limited and no concrete reports are available from this
region. The Sultanate of Oman is a country with an estimated pop-
ulation of 3.5 million. The prevalence estimate of ASD (Autism
Spectrum Disorder) in Oman in the year 2011 was 1.4 per 10,000
children, which is comparatively low [10].
In the current study, 75% of patients were males and 25% were
females, with ratio of 3:1. That is close to a study done by James
et al. who found that autism affects males more than females at
a ratio 4:1 [11]. According to a study done in 14 sites in USA,
ASD prevalence estimates were significantly (p < 0.01) higher
among boys than among girls in all 14 sites, with male-to-female
prevalence ratios ranging from 2.7 in Utah to 7.2 in Alabama
[12]. The specific factors responsible for the higher male preva-
lence in ASD remain unclear. ASD is not the only neurodevelop-
mental condition more common among males—a greater
prevalence in males versus females is also seen in Attention Deficit
Hyperactivity Disorder (ADHD), dyslexia; conduct disorder (CD),
specific language impairment, Tourette Syndrome, and Learning
Difficulties [13].
In the current study, 90% of autistic children have stereotyping
which is characteristic for autism and non specific eating disorders.
A study by Gal et al. stated that autistic children exceeded other
groups of developmental and sensory disabilities in the frequencyof 15 stereotypic movements. Also, the study stated that autistic
children have self injurious behavior as a severe form of stereo-
typed movements [14].
In our study, all autistic children (100%) had lower IQ than con-
trols and all in the range of 47–60. The Centers for Disease Control
and Prevention reported in 2009 that the proportion of children
with autistic traits who have IQs below 70 ranges from 29.3 per-
cent in Colorado to 51.2 percent in South Carolina [15].
In our study, all our autistic children and controls have taken
MMR vaccine with no difference between the two groups. This is
in accordance with De Stefano who published a brief summary of
several studies in the USA and proved that there is no relation of
MMR vaccine with increasing autism cases [16]. Also, Melissa
et al. stated that the evidence clearly shows that there is no link
between vaccination against measles, mumps, and rubella, and
an increased risk for the development of autism [17].
In our study, 5% of our patients had a history of convulsions.
Blazek and Sansa stated that epilepsy is common in autism, with
prevalence rates ranging from 7% to 46% [18]. While Kogan et al.,
stated that about 22–30% of children with ASD develop seizures
with no specific underlying pathology, and no obvious or classic
EEG changes [19]. Epileptic symptoms in children with ASD were
recently considered to be related to immune-mediated pathogene-
sis. In fact, ASD are associated with some immune dysfunction,
such as elevated antibody levels directed against the fetal brain [20].
In our study 85% of our patients have absent eye contact and all
our patients (100%) have abnormal speech. This is in accordance
with Klin et al., who stated that children with autism tend to focus
on the area around the mouth rather than on the socially informa-
tive eye area and on static objects rather than moving people [21].
Also, Bonneh et al. stated that children with ASD who can speak
often exhibit abnormal voice quality and speech prosody, but the
exact nature and underlying mechanisms of these abnormalities,
as well as their diagnostic power are currently unknown [22]. Hub-
bard and Trauner reported increased pitch range in ASD children
[23].
In the current study, 90% of our patients (18 patients) have
delay in motor development. This is in accordance with Esposito
and Venuti who said that ASD patients showed a range of gross
motor problems, including delays in motormilestones, abnormal
muscle tone (velocity-dependent resistance to stretch), abnormal
reflexes, and postural asymmetries [24].
Recent studies have implicated physiological and metabolic
abnormalities in ASD and other psychiatric disorders, particularly
immune dysregulation or inflammation, oxidative stress, mito-
chondrial dysfunction and environmental toxicant exposures [25].
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remain controversial in many cases, but both genetic and environ-
mental factors have been implicated [26]. Copper is a trace ele-
ment present in all tissues and is required for cellular
respiration, neurotransmitter biosynthesis, pigment formation,
and connective tissue strength, and is a cofactor for numerous
enzymes and plays an important role in central nervous system
development. Copper may be involved in free radical production
that results in mitochondrial damage, DNA breakage, and neuronal
injury [27]. Copper is a component of several metalloenzymes that
are linked to dopamine synthesis, in biochemical pathways involv-
ing either antagonism of dopamine production or catalysis of its
breakdown. As dopamine is implicated in autism, copper home-
ostasis may be particularly relevant. An excess of copper may be
associated with dopamine dysregulation [28].
In the current study, copper is statistically higher in patients
than controls (P < 0.001). Similarly Faber S et al. reported high
levels of serum copper in young children with autism [29]. Also a
study by Russo and Robert stated that autistic children have signif-
icantly elevated plasma levels of copper (P = 0.0133) [30].
As well Elsheshtawy E et al. stated that the level of copper was
significantly higher in cases than in controls. They also stated that
the level of copper in hair was significantly associated with higher
CARS scores [26]. Also in another study by Lakshmi Priya MD and
Geetha A higher levels of copper was found in these children when
compared with controls. Their study also concluded that the level
of copper could be associated with the children’s degree of autism
severity [31].
Ceruloplasmin is a ferroxidase enzyme and is the major copper-
carrying protein in the blood. It is an enzyme synthesized in the
liver containing 6 atoms of copper in its structure. The antioxidant
effects of ceruloplasmin could have important implications for var-
ious neurodegenerative diseases such as Parkinson’s disease, Aut-
ism and Alzheimer’s disease [4]. In our study, there was
statistically high difference between mean level of ceruloplasmin
in patients and controls (P = 0.009). On the other hands Chauhan
et al. reported lower levels of ceruloplasmin in 68% of children with
autism as compared to their developmentally normal siblings in
the USA [32]. This difference can be explained by the fact that ceru-
loplasmin is an acute phase reactant that can be elevated in com-
mon infections.
6. Conclusion
Serum copper level is high among autistic children in our study,
so measurement of serum copper is useful in patients with autism.
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